+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

An elucidation of the arachidonic acid cascade. Discovery of prostaglandins, thromboxane and leukotrienes



An elucidation of the arachidonic acid cascade. Discovery of prostaglandins, thromboxane and leukotrienes



Drugs 33(Suppl. 1): 2-9



Arachidonic acid is normally stored in membrane-bound phospholipids and released by the action of phospholipases. Enzymatic conversion of released arachidonic acid into biologically active derivatives proceeds through one of several routes. Cyclo-oxygenase converts arachidonic acid to unstable cyclic endoperoxides from which prostaglandins, prostacyclin and thromboxanes are derived. Formation of the leukotrienes from arachidonic acid is initiated by the action of 5-lipoxygenase producing leukotriene A4. Hydrolysis of leukotriene A4, or the incorporation of glutathione results in the formation of leukotriene B4 and C4, respectively. In addition, 12- and 15-lipoxygenase can catalyse arachidonic acid conversion and lipoxins A and B are amongst the possible products. Many of these metabolites of arachidonic acid feature prominently in the development of inflammation. Prostaglandin E2 and prostacyclin are potent vasodilators, while leukotriene D4 causes cellular adhesion, chemotaxis of neutrophils and degranulation. Leukotrienes C4, D4 and E4 contribute to inflammation by increasing vascular permeability. Leukotrienes are also believed to play an important pathophysiological role in allergic broncho-constriction of asthma. Through pharmacological intervention in the arachidonic acid cascade various anti-inflammatory agents have been developed. These include aspirin-like drugs, which inhibit cyclo-oxygenase. Corticosteroids appear to indirectly inhibit phospholipases thus preventing release of arachidonic acid. Future progress in this field is likely to produce drugs which antagonise arachidonic acid derivatives or inhibit the enzymes involved in their synthesis with greater specificity.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039244123

Download citation: RISBibTeXText

PMID: 3036460


Related references

Metabolic pathways of arachidonic acid: prostaglandins, thromboxane and leukotrienes. Archives des Maladies du Coeur et des Vaisseaux 78 Spec No: 21-27, 1985

The arachidonic acid cascade prostaglandins thromboxanes and leukotrienes. Inflammation 8(Suppl.): S15-S26, 1984

The arachidonic acid cascade. The prostaglandins, thromboxanes and leukotrienes. Inflammation 8 Suppl: S15-S25, 1984

Circulating soluble fibrin as potent effector of thromboxane mediated pulmonary vasoconstriction new link between coagulation cascade and arachidonic acid cascade. Journal of Clinical Chemistry & Clinical Biochemistry 23(9): 548, 1985

Leukocytes and derivatives of arachidonic acid, prostaglandins and leukotrienes. Revue Medicale de Liege 40(24): 836-838, 1985

Prostaglandins, thromboxanes, leukotrienes, and cytochrome P-450 metabolites of arachidonic acid. New Horizons 1(1): 60-69, 1993

Prostaglandins, thromboxanes, leukotrienes, and related arachidonic acid metabolites. Natural Product Reports 5(1): 1-45, 1988

An Elucidation of the Arachidonic Acid Cascade. Drugs 33(1 Suppl.): 2-9, 1987

Role of metabolites of arachidonic acid (prostaglandins and leukotrienes) in allergic reactions. Postepy Higieny i Medycyny Doswiadczalnej 39(4): 365-382, 1985

Prostaglandins, leukotrienes, and other arachidonic acid metabolites in the pathogenesis of otitis media. Laryngoscope 98(9): 980-993, 1988

Update on arachidonic acid cascade Leukotrienes and lipoxins in disease models. Serhan, C N , Ward, P A Current Inflammation Research Series; Molecular and cellular basis of inflammation 51-92, 1999

Stimulation of arachidonic acid metabolism and generation of thromboxane A2 by leukotrienes B4, C4 and D4 in guinea-pig lung in vitro. British Journal of Pharmacology 77(2): 267-275, 1982

Release of arachidonic acid and formation of prostaglandins hydroxyeicosatetraenoic acids and leukotrienes by complement attack on macrophages. Federation Proceedings 44(6): 1875, 1985

Analysis of leukotrienes, prostaglandins, and other oxygenated metabolites of arachidonic acid by high-performance liquid chromatography. Analytical Biochemistry 140(1): 87-94, 1984

Effect of arachidonic acid, fatty acids, prostaglandins, and leukotrienes on volume regulation in Ehrlich ascites tumor cells. Journal of Membrane Biology 98(3): 207-221, 1987